Viking Therapeutics (VKTX) Accounts Payables (2014 - 2026)
Viking Therapeutics' Accounts Payables was $69.01 million in Q2 2026, compared with $5.49 million a year earlier and up 2.7% from the prior quarter.
Powered by 
Analysis
Viking Therapeutics (VKTX) Accounts Payables (2014 - 2026) Analysis & Trends
At the end of FY2025, Accounts Payables at Viking Therapeutics came in at $53.25 million, up 442.7% from FY2024.
- Accounts Payables shows a five-year compound annual growth rate of 67.9% (FY2020 to FY2025).
- In earlier years, Accounts Payables was $9.81 million in FY2024 (+30.6%), $7.51 million in FY2023 (-11.9%), $8.53 million in FY2022 (+490.7%) and $1.44 million in FY2021 (-63.8%).
- The Q2 2026 figure marks the highest quarterly Accounts Payables in data going back to Q4 2014.
- Compared with a year earlier, Accounts Payables was higher in four of the last six quarters, with growth averaging 191.2%.
- The best year-over-year quarter for Accounts Payables over five years was Q1 2026 (growth of 772.3%); the worst was Q3 2024 (a decline of 95.6%).
- Per Business Quant data, VKTX's Accounts Payables in the three quarters before Q2 2026 was $67.18 million (Q1 2026), $53.25 million (Q4 2025) and $4.41 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Viking Therapeutics | 3.07 Bn | 545.20 Mn | - | 69.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.01 Mn |
| Mar 31, 2026 | 67.18 Mn |
| Dec 31, 2025 | 53.25 Mn |
| Sep 30, 2025 | 4.41 Mn |
| Jun 30, 2025 | 5.49 Mn |
| Mar 31, 2025 | 7.70 Mn |
| Dec 31, 2024 | 9.81 Mn |
| Sep 30, 2024 | 254,000.00 |
| Jun 30, 2024 | 11.09 Mn |
| Mar 31, 2024 | 5.23 Mn |
| Dec 31, 2023 | 7.51 Mn |
| Sep 30, 2023 | 5.71 Mn |
| Jun 30, 2023 | 5.61 Mn |
| Mar 31, 2023 | 3.80 Mn |
| Dec 31, 2022 | 8.53 Mn |
| Sep 30, 2022 | 3.14 Mn |
| Jun 30, 2022 | 6.10 Mn |
| Mar 31, 2022 | 3.12 Mn |
| Dec 31, 2021 | 1.44 Mn |
| Sep 30, 2021 | 2.85 Mn |
API Access
Viking Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();